1. Home
  2. CJET vs XRTX Comparison

CJET vs XRTX Comparison

Compare CJET & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chijet Motor Company Inc.

CJET

Chijet Motor Company Inc.

HOLD

Current Price

$0.87

Market Cap

5.0M

ML Signal

HOLD

Logo XORTX Therapeutics Inc.

XRTX

XORTX Therapeutics Inc.

HOLD

Current Price

$0.61

Market Cap

4.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CJET
XRTX
Founded
2009
2011
Country
China
Canada
Employees
N/A
N/A
Industry
Auto Manufacturing
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0M
4.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CJET
XRTX
Price
$0.87
$0.61
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.0M
50.0K
Earning Date
03-26-2026
11-17-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,107,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.82
$0.52
52 Week High
$299.00
$1.79

Technical Indicators

Market Signals
Indicator
CJET
XRTX
Relative Strength Index (RSI) 38.48 46.51
Support Level $0.82 $0.61
Resistance Level $1.28 $0.67
Average True Range (ATR) 0.29 0.03
MACD -0.14 0.01
Stochastic Oscillator 2.07 50.45

Price Performance

Historical Comparison
CJET
XRTX

About CJET Chijet Motor Company Inc.

Chijet Motor Company Inc is engaged in the development, manufacture, sales, and service of new energy vehicles (NEV), hybrid vehicles and traditional fuel vehicles in China. New energy vehicles refer to plug-in electric vehicles, including battery electric vehicles, plug-in hybrid (PHEV) electric vehicles, and fuel cell electric vehicles. Its passenger vehicles include small cars, sedans, and sports utility vehicles, or SUVs, and commercial vehicles include light trucks and vans. The company generates all of its revenue from PRC.

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.

Share on Social Networks: